The MCV Foundation is hosting a special virtual event as Sickle Cell Awareness Month comes to a close.
VCU Health continues its national and global leadership in implanting and researching total artificial heart technology.
A promising approach to discovering new cancer treatments is at the heart of MCV Campus research to interfere with the cell signals that instigate cancerous growth.
Champion water skier and School of Dentistry alum John Howell elected to receive the WATCHMAN so he could continue to shred the wake without fear of bleeding complications due to his Afib.
VCU Health leads a national clinical trial that could mean the end of blood thinners for AFib patients.
An ongoing research project on smell and taste loss related to COVID-19 received national media attention and has inspired support for continuing the effort.
VCU researchers have discovered a solution that stabilizes patients experiencing traumatic shock and are pursuing commercialization of the lifesaving compound.
The MCV Campus has created a national model for how to address disparities and quality of care in sickle cell disease, and the research into new treatments remains promising.
For a Monument Avenue 10K unlike any other, more than 100 individual team members and team captains still stepped up to run, walk and fundraise for Massey Cancer Center.
A grieving husband finds solace in supporting VCU Massey Cancer Center after his wife’s death.
Steve and Lisa Bresenoff Feierstein have always been forward thinking people. Together they are supporting innovation and leadership initiatives at the VCU School of Nursing.
Expertise in the body’s inflammation responses positioned two researchers on the MCV Campus to play a leading role in evaluating potential treatments for severe COVID-19 patients in a global trial.